mark cuban semaglutide Cost Plus Drug Company Mark Cuban's Cost Plus partners

Staying abreast of potential side effects, understanding the nuances of the new prescription, and accessing support from healthcare specialists can help patients lead their way through the transition week by week

Common local reactions include: Some patients report less nausea when injecting in the thigh compared to the abdomen

Guerry, D., Synnestvedt, M., Elder, D

As Healio previously reported, the FDA removed tirzepatide (Mounjaro/Zepbound, Eli Lilly) and semaglutide (Ozempic/Wegovy, Novo Nordisk) from its drug shortage list in 2024 and 2025, respectively, and now prohibits both 503A compounding pharmacies and 503B outsourcing facilities from distributing compounded versions of the drug